Abstract
Stroke is the leading cause of disability in developed countries, and investigations to identify ways to recover lost neurological function continue. The potential of stem cell therapy could be enormous, but current knowledge and techniques remain limited. In this review article, findings related to the therapeutic potential of acceleration of endogenous neurogenesis and neuronal stem cell transplantation are introduced. The therapeutic effects of acceleration of endogenous neurogenesis have been shown to be mild, but they improve neurological function significantly, and clinical trials are ongoing. In contrast, the potential of neural stem cell transplantation has been reported in many basic experiments, but current basic knowledge and techniques are likely to be insufficient to proceed to clinical trials. The possible missing elements for successful neuronal stem cell transplantation in patients with cerebral infarction are discussed.
Keywords: angiogenesis, cell therapy, cerebral infarction, clinical trial, neural stem cells, neurogenesis, stroke, subventricular zone, vascular endothelial growth factor, granulocyte colony-stimulating factor, brain-derived neurotrophic factor, erythropoietin, endothelial stem/progenitor cell, embolic stem cell, induced pluripotent stem cell, CD34-positive cell, bone marrow mononuclear cell, T-lymphocyte, CD4-positive lymphocyte, CD8-positive lymphocyte, mesenchymal cell, inflammation, apoptotic cell death, immune system, therapeutic time window
Current Signal Transduction Therapy
Title: The Therapeutic Potential of Neural Stem Cells in Cerebral Ischemia
Volume: 6 Issue: 3
Author(s): Yukiko Kasahara, Takayuki Nakagomi, Akiko Nakano-Doi, Tomohiro Matsuyama and Akihiko Taguchi
Affiliation:
Keywords: angiogenesis, cell therapy, cerebral infarction, clinical trial, neural stem cells, neurogenesis, stroke, subventricular zone, vascular endothelial growth factor, granulocyte colony-stimulating factor, brain-derived neurotrophic factor, erythropoietin, endothelial stem/progenitor cell, embolic stem cell, induced pluripotent stem cell, CD34-positive cell, bone marrow mononuclear cell, T-lymphocyte, CD4-positive lymphocyte, CD8-positive lymphocyte, mesenchymal cell, inflammation, apoptotic cell death, immune system, therapeutic time window
Abstract: Stroke is the leading cause of disability in developed countries, and investigations to identify ways to recover lost neurological function continue. The potential of stem cell therapy could be enormous, but current knowledge and techniques remain limited. In this review article, findings related to the therapeutic potential of acceleration of endogenous neurogenesis and neuronal stem cell transplantation are introduced. The therapeutic effects of acceleration of endogenous neurogenesis have been shown to be mild, but they improve neurological function significantly, and clinical trials are ongoing. In contrast, the potential of neural stem cell transplantation has been reported in many basic experiments, but current basic knowledge and techniques are likely to be insufficient to proceed to clinical trials. The possible missing elements for successful neuronal stem cell transplantation in patients with cerebral infarction are discussed.
Export Options
About this article
Cite this article as:
Kasahara Yukiko, Nakagomi Takayuki, Nakano-Doi Akiko, Matsuyama Tomohiro and Taguchi Akihiko, The Therapeutic Potential of Neural Stem Cells in Cerebral Ischemia, Current Signal Transduction Therapy 2011; 6 (3) . https://dx.doi.org/10.2174/157436211797484038
DOI https://dx.doi.org/10.2174/157436211797484038 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Atypical Neurotransmitters and the Neurobiology of Depression
CNS & Neurological Disorders - Drug Targets Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Mediterranean Diet and Dementia of the Alzheimer Type
Current Aging Science Biomarkers in the Diagnosis of Ventilator-Associated Pneumonia
Current Respiratory Medicine Reviews L-Arginine in the Prevention and Treatment of Cardiovascular Disease: From Basic to Clinical Research Studies
Vascular Disease Prevention (Discontinued) The Significance of Oxidized Low-Density Lipoprotein in Body Fluids as a Marker Related to Diseased Conditions
Current Medicinal Chemistry Myocardial Contrast Echocardiography: Role in Clinical Cardiology
Current Vascular Pharmacology Advanced Glycation End Products (AGEs) and Cardiovascular Disease (CVD) in Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry Regulation of Cholesterol Biosynthesis and Absorption: Ultimate Management of Dyslipidemia with Statin and Ezetimibe
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Promise of Cholesteryl Ester Transfer Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease
Current Pharmaceutical Design Evaluation and Management of Asymptomatic Bradyarrhythmias
Current Cardiology Reviews Cholesteryl Ester Transfer Protein (CETP) Inhibitors
Current Topics in Medicinal Chemistry Dietary Technologies to Optimize Healing from Injury-Induced Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Nanotechnology Based Diagnostic and Therapeutic Strategies for Neuroscience with Special Emphasis on Ischemic Stroke
Current Medicinal Chemistry Vitamin E - Occurrence, Biosynthesis by Plants and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry Sex Differences in Clinical Outcomes of Patients with Stable Coronary Artery Disease after Percutaneous Coronary Intervention
Current Pharmaceutical Design Risk Factors for Myocardial Infarction in Women and Men: A Review of the Current Literature
Current Pharmaceutical Design Pharmacological Interference With Protein-protein Interactions of Akinase Anchoring Proteins as a Strategy for the Treatment of Disease
Current Drug Targets Agave (Agave spp.) and its Traditional Products as a Source of Bioactive Compounds
Current Bioactive Compounds Bile Acids and Farnesoid X Receptor: Novel Target for the Treatment of Diabetic Cardiomyopathy
Current Protein & Peptide Science